SGHT insider trading
HealthcareSight Sciences, Inc.: insider trade history from SEC Form 4 filings.
About Sight Sciences, Inc.
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases. The company operates in two segments, Surgical Glaucoma and Dry Eye. Its products include OMNI surgical system, an implant-free, handheld, single-use, therapeutic technology that enables ophthalmic surgeons to perform a comprehensive procedure indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, as well as for the catheterization and transluminal viscodilation of Schlemm's canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma; and SION surgical instrument, a bladeless manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The company also provides TearCare system, a dry eye device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
Company website: www.sightsciences.com
SGHT insider activity at a glance
FilingIQ tracks 244 insider transactions for SGHT in filings since Jul 19, 2021. The most recent transaction is dated Oct 2, 2026.
Across the full history, 44 open-market purchases
and 89 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on SGHT insider trades is 51.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest SGHT Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for SGHT?
- FilingIQ tracks 244 Form 4 insider transactions for SGHT (Sight Sciences, Inc.), covering filings from Jul 19, 2021 onwards. 6 of those are dated within the last 90 days.
- Are SGHT insiders net buyers or net sellers?
- Across the full Form 4 history for SGHT, 44 transactions (18%) were open-market purchases and 89 (36%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does SGHT insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is SGHT in?
- Sight Sciences, Inc. (SGHT) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $286.04M.
Methodology & sources
Every SGHT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.